Yaras Brandon bought ATYR
October 1, 2026 · Form 4 insider transaction
Yaras Brandon bought 410,000 shares of aTyr Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
410,000
Price
$0.00
Total value
N/A
InsiderYaras Brandon
RoleOfficer
CompanyaTyr Pharma, Inc. (ATYR)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 1, 2026
Filing dateOctober 1, 2026
Shares owned after410,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning November 1, 2026, such that this option will be fully exercisable on November 1, 2030. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.